Javier Cid‐Ruzafa

1.7k total citations · 1 hit paper
20 papers, 1.1k citations indexed

About

Javier Cid‐Ruzafa is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Javier Cid‐Ruzafa has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Javier Cid‐Ruzafa's work include Diabetes Treatment and Management (11 papers), Diabetes Management and Research (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Javier Cid‐Ruzafa is often cited by papers focused on Diabetes Treatment and Management (11 papers), Diabetes Management and Research (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Javier Cid‐Ruzafa collaborates with scholars based in United States, United Kingdom and Russia. Javier Cid‐Ruzafa's co-authors include Javier Damián, Luba Nalysnyk, Philip Rotella, Dirk Eßer, М. В. Шестакова, Peter Fenici, Kamlesh Khunti, Marília Brito Gomes, Niklas Hammar and Antonio Nicolucci and has published in prestigious journals such as Journal of the American College of Cardiology, American Journal of Clinical Nutrition and Diabetes.

In The Last Decade

Javier Cid‐Ruzafa

20 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature

2012 380 citations Luba Nalysnyk, Javier Cid‐Ruzafa et al. European Respiratory Review profile →

Peers

Javier Cid‐Ruzafa

PRM

EDM

PHYSI

PHEOH

William C. Maier United States

Ho-Chun Choi South Korea

Adriana J. van Ballegooijen Netherlands

Patrick J. Blatchford United States

Christiano Argano Italy

Patrizia Natale Italy

Enver Hasanoğlu Türkiye

Irene Bretón Lesmes Spain

Qing Qiao China

Keiichi Sumida United States

William C. Maier United States

Javier Cid‐Ruzafa

348 ×0.9

PRM

357 ×1.2

EDM

438 ×2.2

PHYSI

97 ×0.5

PHEOH

106 ×0.6

Citations per year, relative to Javier Cid‐Ruzafa Javier Cid‐Ruzafa (= 1×) peers William C. Maier

Countries citing papers authored by Javier Cid‐Ruzafa

Since Specialization

Citations

This map shows the geographic impact of Javier Cid‐Ruzafa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Cid‐Ruzafa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Cid‐Ruzafa more than expected).

Fields of papers citing papers by Javier Cid‐Ruzafa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Cid‐Ruzafa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Cid‐Ruzafa. The network helps show where Javier Cid‐Ruzafa may publish in the future.

Co-authorship network of co-authors of Javier Cid‐Ruzafa

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Cid‐Ruzafa. A scholar is included among the top collaborators of Javier Cid‐Ruzafa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Cid‐Ruzafa. Javier Cid‐Ruzafa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Duong, Mai, Hungta Chen, Nahila Justo, et al.. (2022). PREVALENCE AND CHARACTERISTICS OF HEART FAILURE WITH PRESERVED, MILDLY REDUCED, AND REDUCED EJECTION FRACTION IN SPAIN: A RETROSPECTIVE COHORT STUDY USING BIGPAC DATABASE. Journal of the American College of Cardiology. 79(9). 454–454. 1 indexed citations

Hogea, Cosmina, Yevgeniy Samyshkin, Eric M. Maiese, et al.. (2022). An Epidemiology Model for Estimating the Numbers of US Patients With Multiple Myeloma by Line of Therapy and Treatment Exposure. Value in Health. 25(12). 1977–1985. 1 indexed citations

Gomes, Marília Brito, Fengming Tang, Hungta Chen, et al.. (2022). Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER Study. Frontiers in Endocrinology. 13. 831676–831676. 17 indexed citations

Charbonnel, B, Hungta Chen, Javier Cid‐Ruzafa, et al.. (2022). Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second‐line glucose‐lowering therapy: The global DISCOVER study. Diabetes Obesity and Metabolism. 25(1). 46–55. 3 indexed citations

Nicolucci, Antonio, Hungta Chen, Javier Cid‐Ruzafa, et al.. (2021). Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER study. Diabetes Research and Clinical Practice. 180. 108974–108974. 3 indexed citations

Patel, Krishna, Marília Brito Gomes, B Charbonnel, et al.. (2020). Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study. Diabetes Obesity and Metabolism. 23(1). 39–48. 7 indexed citations

Khunti, Kamlesh, Marília Brito Gomes, Mikhail Kosiborod, et al.. (2020). Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme. BMJ Open. 10(8). e034613–e034613. 7 indexed citations

Rathmann, Wolfgang, B Charbonnel, Marília Brito Gomes, et al.. (2020). Socioeconomic factors associated with hypoglycaemia in patients starting second-line glucose-lowering therapy: The DISCOVER study. Diabetes Research and Clinical Practice. 165. 108250–108250. 5 indexed citations

Gomes, Marília Brito, Wolfgang Rathmann, B Charbonnel, et al.. (2019). Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study. Diabetes Research and Clinical Practice. 151. 20–32. 66 indexed citations

10.

Arnold, Suzanne V., Hungta Chen, Javier Cid‐Ruzafa, et al.. (2019). 420-P: Micro- and Macrovascular Events in Patients with T2D—Results from the Global DISCOVER Study. Diabetes. 68(Supplement_1). 2 indexed citations

11.

Khunti, Kamlesh, Hungta Chen, Javier Cid‐Ruzafa, et al.. (2019). Glycaemic control in patients with type 2 diabetes initiating second‐line therapy: Results from the global DISCOVER study programme. Diabetes Obesity and Metabolism. 22(1). 66–78. 24 indexed citations

12.

Gomes, Marília Brito, Fengming Tang, Hungta Chen, et al.. (2019). 1279-P: Socioeconomic Factors Associated with Poor Glycemic Control in People with Type 2 Diabetes: The DISCOVER Study. Diabetes. 68(Supplement_1). 1 indexed citations

13.

Nicolucci, Antonio, B Charbonnel, Marília Brito Gomes, et al.. (2019). Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second‐line therapy: Results from the global DISCOVER study programme. Diabetes Obesity and Metabolism. 21(11). 2474–2485. 37 indexed citations

14.

Kosiborod, Mikhail, Marília Brito Gomes, Antonio Nicolucci, et al.. (2018). Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Cardiovascular Diabetology. 17(1). 150–150. 174 indexed citations

15.

Khunti, Kamlesh, Hungta Chen, Javier Cid‐Ruzafa, et al.. (2018). Individualized HbA1c Targets in People with Type 2 Diabetes Initiating Second-Line Therapy—The Global DISCOVER Study. Diabetes. 67(Supplement_1). 2 indexed citations

16.

Khunti, Kamlesh, Thomas Godec, Jesús Medina, et al.. (2017). Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second‐line therapy after metformin monotherapy: R etrospective data for 10 256 individuals from the U nited K ingdom and G ermany. Diabetes Obesity and Metabolism. 20(2). 389–399. 40 indexed citations

17.

Nalysnyk, Luba, Javier Cid‐Ruzafa, Philip Rotella, & Dirk Eßer. (2012). Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. European Respiratory Review. 21(126). 355–361. 380 indexed citations breakdown →

18.

Caulfield, Laura E., Sheila K. West, Yolanda Barrón, & Javier Cid‐Ruzafa. (1999). Anthropometric status and cataract: the Salisbury Eye Evaluation project. American Journal of Clinical Nutrition. 69(2). 237–242. 43 indexed citations

19.

Cid‐Ruzafa, Javier, Laura E. Caulfield, Yolanda Barrón, & Sheila K. West. (1999). Nutrient Intakes and Adequacy Among an Older Population on the Eastern Shore of Maryland. Journal of the American Dietetic Association. 99(5). 564–571. 31 indexed citations

20.

Cid‐Ruzafa, Javier & Javier Damián. (1997). Valoración de la discapacidad física: el indice de Barthel. Revista Española de Salud Pública. 71(2). 127–137. 277 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact